New eye drop shows promise for glaucoma in early trial
NCT ID NCT06144918
First seen Jan 24, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study tested a new eye drop called SBI-100 in 56 adults with glaucoma or high eye pressure. Participants used the drop twice daily for 14 days. Researchers measured how well it lowered eye pressure and checked for side effects. The goal is to find a safe and effective treatment to control eye pressure long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eye Research Foundation
Newport Beach, California, 92663, United States
-
Global Research Management, Inc.
Glendale, California, 91204, United States
-
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania, 16066, United States
Conditions
Explore the condition pages connected to this study.